EP3559034
COMBINATION THERAPY OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND 4-1BB (CD137) AGONISTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.12.2017EP published:
2.12.2020EP application number:
17829176.1
EPO information:
European Patent Register
Max expiry date:
17.12.2037
Title:
COMBINATION THERAPY OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND 4-1BB (CD137) AGONISTS
Timeline
Today
18.12.2017EP application
2.12.2020EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel, CH
Inventor
Name:
BACAC, MarinaAddress:
8952 Schlieren, CH
Name:
FERRARA KOLLER, ClaudiaAddress:
8952 Schlieren, CH
Name:
KLEIN, ChristianAddress:
8952 Schlieren, CH
Name:
PERRO, MarioAddress:
8952 Schlieren, CH
Name:
SAM, JohannesAddress:
8952 Schlieren, CH
Name:
UMAÑA, PabloAddress:
8952 Schlieren, CH
Name:
XU, WeiAddress:
8952 Schlieren, CH
Priority
Number:
16205493Date:
20.12.2016Country:
EP
Classification
Categories:
C07K 16/28, A61K 39/00, A61K 38/19, A61P 35/00, A61P 35/02, A61P 43/00